Drug companies dramatically cut HPV vaccine costs for girls in developing world
A dramatic drop in the cost of vaccines that protect against infection with HPV – the family of viruses responsible for cervical cancer – could result in millions of girls being immunized in the years to come. The two companies that make HPV vaccine, Merck & Co. and GlaxoSmithKline, will drop their …
Read more on theglobeandmail.com